These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35981800)

  • 21. Nonischemic or Dual Cardiomyopathy in Patients With Coronary Artery Disease.
    Bawaskar P; Thomas N; Ismail K; Guo Y; Chhikara S; Athwal PSS; Ranum A; Jadhav A; Hooker Mendez A; Nadkarni I; Frerichs D; Velangi P; Ergando T; Akram H; Kanda A; Shenoy C
    Circulation; 2024 Mar; 149(11):807-821. PubMed ID: 37929565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late gadolinium enhancement and the risk of ventricular arrhythmias and sudden death in NYHA class I patients with non-ischaemic cardiomyopathy.
    Di Marco A; Brown P; Mateus G; Faga V; Nucifora G; Claver E; Viedma J; Galvan F; Bradley J; Dallaglio PD; de Frutos F; Miller CA; Comín-Colet J; Anguera I; Schmitt M
    Eur J Heart Fail; 2023 May; 25(5):740-750. PubMed ID: 36781200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ventricular arrhythmias in patients with newly diagnosed nonischemic cardiomyopathy: Insights from the PROLONG study.
    Duncker D; König T; Hohmann S; Bauersachs J; Veltmann C
    Clin Cardiol; 2017 Aug; 40(8):586-590. PubMed ID: 28333373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implantable cardioverter defibrillators for primary prevention in patients with ischemic and non-ischemic cardiomyopathy: A meta-analysis.
    Jaiswal V; Taha AM; Joshi A; Deb N; Kanagala SG; Nebuwa C; Ang SP; Halder A; Rajak K; Jha M; Pallath Harshakumar S; Mattumpuram J
    Curr Probl Cardiol; 2024 Feb; 49(2):102198. PubMed ID: 37952790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic role of late gadolinium enhancement on cardiac magnetic resonance in patients with nonischemic cardiomyopathy and reduced ejection fraction, implanted with cardioverter defibrillators for primary prevention. A systematic review and meta-analysis.
    Anagnostopoulos I; Kousta M; Kossyvakis C; Lakka E; Paraskevaidis NT; Schizas N; Alexopoulos N; Deftereos S; Giannopoulos G
    J Interv Card Electrophysiol; 2022 Apr; 63(3):523-530. PubMed ID: 34218421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substrate Spatial Complexity Analysis for the Prediction of Ventricular Arrhythmias in Patients With Ischemic Cardiomyopathy.
    Okada DR; Miller J; Chrispin J; Prakosa A; Trayanova N; Jones S; Maggioni M; Wu KC
    Circ Arrhythm Electrophysiol; 2020 Apr; 13(4):e007975. PubMed ID: 32188287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death.
    Iles L; Pfluger H; Lefkovits L; Butler MJ; Kistler PM; Kaye DM; Taylor AJ
    J Am Coll Cardiol; 2011 Feb; 57(7):821-8. PubMed ID: 21310318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CinE caRdiac magneTic resonAnce to predIct veNTricular arrhYthmia (CERTAINTY).
    Krebs J; Mansi T; Delingette H; Lou B; Lima JAC; Tao S; Ciuffo LA; Norgard S; Butcher B; Lee WH; Chamera E; Dickfeld TM; Stillabower M; Marine JE; Weiss RG; Tomaselli GF; Halperin H; Wu KC; Ashikaga H
    Sci Rep; 2021 Nov; 11(1):22683. PubMed ID: 34811411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arrhythmia and Survival Outcomes Among Black Patients and White Patients With a Primary Prevention Defibrillator.
    Younis A; Ali S; Hsich E; Goldenberg I; McNitt S; Polonsky B; Aktas MK; Kutyifa V; Wazni OM; Zareba W; Goldenberg I
    Circulation; 2023 Jul; 148(3):241-252. PubMed ID: 37459413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac MRI scar patterns differ by sex in an implantable cardioverter-defibrillator and cardiac resynchronization therapy cohort.
    Loring Z; Strauss DG; Gerstenblith G; Tomaselli GF; Weiss RG; Wu KC
    Heart Rhythm; 2013 May; 10(5):659-65. PubMed ID: 23313802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac Magnetic Resonance Scar Imaging for Sudden Cardiac Death Risk Stratification in Patients with Non-Ischemic Cardiomyopathy.
    Kim EK; Chattranukulchai P; Klem I
    Korean J Radiol; 2015; 16(4):683-95. PubMed ID: 26175568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ECG quantification of myocardial scar in cardiomyopathy patients with or without conduction defects: correlation with cardiac magnetic resonance and arrhythmogenesis.
    Strauss DG; Selvester RH; Lima JA; Arheden H; Miller JM; Gerstenblith G; Marbán E; Weiss RG; Tomaselli GF; Wagner GS; Wu KC
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):327-36. PubMed ID: 19808427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging.
    Gao P; Yee R; Gula L; Krahn AD; Skanes A; Leong-Sit P; Klein GJ; Stirrat J; Fine N; Pallaveshi L; Wisenberg G; Thompson TR; Prato F; Drangova M; White JA
    Circ Cardiovasc Imaging; 2012 Jul; 5(4):448-56. PubMed ID: 22572740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnetic resonance estimates of the extent and heterogeneity of scar tissue in ICD patients with ischemic cardiomyopathy predict ventricular arrhythmia.
    Zeidan-Shwiri T; Yang Y; Lashevsky I; Kadmon E; Kagal D; Dick A; Laish Farkash A; Paul G; Gao D; Shurrab M; Newman D; Wright G; Crystal E
    Heart Rhythm; 2015 Apr; 12(4):802-8. PubMed ID: 25583153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial tissue characterization by cardiac magnetic resonance imaging using T1 mapping predicts ventricular arrhythmia in ischemic and non-ischemic cardiomyopathy patients with implantable cardioverter-defibrillators.
    Chen Z; Sohal M; Voigt T; Sammut E; Tobon-Gomez C; Child N; Jackson T; Shetty A; Bostock J; Cooklin M; O'Neill M; Wright M; Murgatroyd F; Gill J; Carr-White G; Chiribiri A; Schaeffter T; Razavi R; Rinaldi CA
    Heart Rhythm; 2015 Apr; 12(4):792-801. PubMed ID: 25533585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complexity of scar and ventricular arrhythmias in dilated cardiomyopathy of any etiology: Long-term data from the SCARFEAR (Cardiovascular Magnetic Resonance Predictors of Appropriate Implantable Cardioverter-Defibrillator Therapy Delivery) Registry.
    Pedretti S; Vargiu S; Baroni M; Dellegrottaglie S; Lanzarin B; Roghi A; Milazzo A; Quattrocchi G; Lunati M; Pedrotti P
    Clin Cardiol; 2018 Apr; 41(4):494-501. PubMed ID: 29663442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk stratification in patients with nonischemic cardiomyopathy and ventricular arrhythmias based on quantification of intramural delayed enhancement on cardiac magnetic resonance imaging.
    Ghannam M; Siontis KC; Cochet H; Jais P; Juhoor M; Attili A; Sharaf-Dabbagh G; Latchamsetty R; Jongnarangsin K; Morady F; Bogun F
    J Cardiovasc Electrophysiol; 2020 Jul; 31(7):1762-1769. PubMed ID: 32329161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of ventricular tachyarrhythmias and their susceptibility to antitachycardia pacing termination in patients with ischemic and nonischemic cardiomyopathy: A patient-level meta-analysis of three large clinical trials.
    Cheng A; Joung B; Brown ML; Koehler J; Lexcen DR; Sanders P; Ellenbogen KA
    J Cardiovasc Electrophysiol; 2020 Oct; 31(10):2720-2726. PubMed ID: 32700390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Entropy as a Novel Measure of Myocardial Tissue Heterogeneity for Prediction of Ventricular Arrhythmias and Mortality in Post-Infarct Patients.
    Androulakis AFA; Zeppenfeld K; Paiman EHM; Piers SRD; Wijnmaalen AP; Siebelink HJ; Sramko M; Lamb HJ; van der Geest RJ; de Riva M; Tao Q
    JACC Clin Electrophysiol; 2019 Apr; 5(4):480-489. PubMed ID: 31000102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of the Wearable Cardioverter-Defibrillator in Patients With Newly Diagnosed Cardiomyopathy: A Decade-Long Single-Center Experience.
    Singh M; Wang NC; Jain S; Voigt AH; Saba S; Adelstein EC
    J Am Coll Cardiol; 2015 Dec; 66(23):2607-2613. PubMed ID: 26670060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.